Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer

被引:38
|
作者
van der Sande, Marit E. [1 ]
Maas, Monique [2 ]
Melenhorst, Jarno [3 ]
Breukink, Stephanie O. [3 ]
van Leerdam, Monique E. [4 ]
Beets, Geerard L. [1 ]
机构
[1] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands
[4] Netherlands Canc Inst, Dept Gastroenterol, Amsterdam, Netherlands
关键词
endoscopy; organ preservation; rectal cancer; response assessment; PATHOLOGICAL COMPLETE RESPONSE; CLINICAL COMPLETE RESPONSE; TOTAL MESORECTAL EXCISION; NEOADJUVANT CHEMORADIATION; PREOPERATIVE RADIOTHERAPY; EUROPEAN-SOCIETY; THERAPY; WATCH; MULTICENTER; RECURRENCE;
D O I
10.1097/SLA.0000000000003718
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective and Background: Watch-and-wait approach in rectal cancer relies on the identification of a clinical complete response (CR) after neoadjuvant (chemo)radiotherapy. This is mainly performed by rectal examination. magnetic resonance imaging, and endoscopy. Endoscopy has been less well studied, and the objective of the study is to assess the diagnostic value of endoscopy and the predictive value of endoscopic features for the identification of CR. Patients and Methods: A total of 161 patients with primary rectal cancer undergoing flexible sigmoidoscopy for response assessment after neoadjuvant (chemo)radiotherapy between January 2012 and December 2015 at a single institution were evaluated retrospectively. Three independent readers scored endoscopic features and a confidence level score for a CR. Diagnostic performance of endoscopy and positive predictive value (PPV) of endoscopic features for a CR were calculated. If available, biopsy results were revealed to the reader and a change in confidence level was noted. Reference standard was histology after surgery, or long-term outcome in a watch-and-wait policy. Results: Median time to endoscopy was 9 (interquartile range 8 12) weeks. Area under the receiver operator characteristic curve, sensitivity, specificity. PPV, and negative predictive value for a CR were 0.80 to 0.84, 72% to 94%, 61% to 85%, 63% to 78% and 80% to 89%, respectively. A flat scar was the most predictive feature of a CR (PPV 70%-80%). The PPV of small flat ulcers and large flat ulcers were 40% to 50% and 29% to 33%, respectively. The addition of biopsy results led to a significant change in confidence level score in 4% to 13% of patients. Conclusions: More than 70% of the patients with a luminal CR after neoadjuvant treatment for rectal cancer can be identified by endoscopy at +/- 9 weeks. Together with findings on digital rectal examination (DRE) and magnetic resonance imaging, specific endoscopic features can be used to select patients for an extended observation period to select for organ preservation.
引用
收藏
页码:E541 / E547
页数:7
相关论文
共 50 条
  • [1] Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response
    Ogura, Atsushi
    Chino, Akiko
    Konishi, Tsuyoshi
    Akiyoshi, Takashi
    Kishihara, Teruhito
    Tamegai, Yoshiro
    Ueno, Masashi
    Igarashi, Masahiro
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (03) : 367 - 373
  • [2] Predictive value of flexible proctosigmoidoscopy and laboratory findings for complete clinical responses after neoadjuvant chemoradiotherapy in patients with locally advanced primary rectal cancer: a retrospective cohort study
    Hadizadeh, Alireza
    Kazemi-Khaledi, Hamed
    Fazeli, Mohammad-Sadegh
    Ahmadi-Tafti, Seyed-Mohsen
    Keshvari, Amir
    Akbari-Asbagh, Reza
    Keramati, Mohammad-Reza
    Kazemeini, Alireza
    Fazeli, Amir-Reza
    Behboudi, Behnam
    Parsaei, Mohammadamin
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2024, 39 (01)
  • [3] Clinical Prediction of Pathological Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer
    Huh, Jung Wook
    Kim, Hyeong Rok
    Kim, Young Jin
    DISEASES OF THE COLON & RECTUM, 2013, 56 (06) : 698 - 703
  • [4] Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response
    Atsushi Ogura
    Akiko Chino
    Tsuyoshi Konishi
    Takashi Akiyoshi
    Teruhito Kishihara
    Yoshiro Tamegai
    Masashi Ueno
    Masahiro Igarashi
    International Journal of Colorectal Disease, 2015, 30 : 367 - 373
  • [5] Predictive Value of Magnetic Resonance Complete Response After Neoadjuvant Therapy for Rectal Cancer
    Liu, Charles
    Boncompagni, Ana Carolina A.
    Perrone, Kenneth H.
    Agarwal, Ank A.
    Hur, Dong G.
    Lopez, Ivan
    Sheth, Vipul
    Morris, Arden M.
    JOURNAL OF SURGICAL RESEARCH, 2025, 306 : 474 - 478
  • [6] Watch and Wait in Rectal Cancer After a Complete Response to Chemoradiotherapy- Is It Safe and Are We Doing Enough?
    Wyatt, J.
    Powell, S. G.
    Ahmed, S.
    CLINICAL ONCOLOGY, 2023, 35 (02) : 117 - 123
  • [7] Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer
    Carlomagno, Chiara
    Pepe, Stefano
    D'Armiento, Francesco Paolo
    D'Armiento, Maria
    Cannella, Lucia
    De Stefano, Alfonso
    Crispo, Anna
    Giordano, Marcella
    De Placido, Sabino
    ONCOLOGY, 2010, 78 (5-6) : 369 - 375
  • [8] Complete pathologic response after preoperative rectal cancer chemoradiotherapy
    Ciccocioppo, Anthony
    Stephens, Jacqueline H.
    Hewett, Peter J.
    Rieger, Nicholas A.
    ANZ JOURNAL OF SURGERY, 2009, 79 (06) : 481 - 484
  • [9] Pathologic complete response in patients with neoadjuvant chemoradiotherapy for rectal cancer
    Espinola M, Daniella
    Molina P, Maria E.
    Bellolio R, Felipe
    Gellona, Jose, V
    Bustos C, Mariza
    Zuniga D, Alvaro
    REVISTA CHILENA DE CIRUGIA, 2013, 65 (04): : 333 - 337
  • [10] The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
    Martinez-Useros, J.
    Moreno, I.
    Fernandez-Acenero, M. J.
    Rodriguez-Remirez, M.
    Borrero-Palacios, A.
    Cebrian, A.
    del Pulgar, T. Gomez
    del Puerto-Nevado, L.
    Li, W.
    Puime-Otin, A.
    Perez, N.
    Soengas, M. S.
    Garcia-Foncillas, J.
    BMC CANCER, 2018, 18